SURAKSHA326.20

Suraksha Diagnostic Limited

· Pharma & Health
₹ CrorePeersKRSNAAHEALTHXNEPHROPLUS3BBLACKBIOMcap ₹1,699 Cr
Holding % of Total Shares
12 Months Ending
Q3 FY25
05/12/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Promoter & Group48.7848.7848.7848.8848.9849.0049.1049.10
FII / FPI15.6415.3914.4613.9513.7213.4613.4613.47
DII16.6820.4422.0522.3721.9822.5723.1423.23
Mutual Funds13.9617.6419.2619.5819.4519.4519.7920.05
Latest: 2026-06-30 · 8 quarters of history · click a row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.